Drug-eluting stents in the management of peripheral arterial disease

被引：24

作者：

Bosiers, Marc ^{[1
]}

Cagiannos, Catherine ^{[1
]}

Deloose, Koen ^{[1
]}

Verbist, Jurgen ^{[2
]}

Peeters, Patrick ^{[2
]}

机构：

[1] AZ St Blasius, Dept Vasc Surg, Kroonveldlaan 50, B-9200 Dendermonde, Belgium

[2] Imelda Hosp, Dept Cardiovasc & Thorac Surg, Bonheiden, Belgium

来源：

VASCULAR HEALTH AND RISK MANAGEMENT | 2008年 / 4卷 / 03期

关键词：

critical limb ischemia; drug-eluting stent; below the knee; infrapopliteal; crural limb salvage;

D O I：

10.2147/VHRM.S1712

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Since major meta-analyses of randomized controlled trials in interventional cardiology showed the potential of drug-eluting stents in decreasing restenosis and reintervention rates after coronary artery stenting, one of the next steps in the treatment of arterial occlusive disease is the transfer of the active coating technology towards peripheral arterial interventions. In this manuscript, we aim to provide a literature overview on available peripheral (lower limb, renal, and supra-aortic) drug-eluting stent applications, debate the cost implications, and give recommendations for future treatment strategies.

引用

页码：553 / 559

页数：7

共 40 条

[31]

Scheinert Dierk, 2006, EuroIntervention, V2, P169

[32] Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting [J].

Schwarzmaier-D'Assie, Alexandra ;

Karnik, Ronald ;

Bonner, Gerhard ;

Vavrik, Joachim ;

Slany, Joerg .

JOURNAL OF ENDOVASCULAR THERAPY, 2007, 14 (01) :106-109

[33] Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-Month angiographic results from a nonrandomized prospective single-center study [J].

Siablis, D ;

Kraniotis, P ;

Karnabatidis, D ;

Kagadis, GC ;

Katsanos, K ;

Tsolakis, J .

JOURNAL OF ENDOVASCULAR THERAPY, 2005, 12 (06) :685-695

[34]

Siablis D, 2007, J ENDOVASC THER, V14, P241, DOI 10.1583/1545-1550(2007)14[241:SVBSAS]2.0.CO

[35]

[36] One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS Stent the TAXUS-IV trial [J].

Stone, GW ;

Ellis, SG ;

Cox, DA ;

Hermiller, J ;

O'Shaughnessy, C ;

Mann, JT ;

Turco, M ;

Caputo, R ;

Bergin, P ;

Greenberg, J ;

Popma, JJ ;

Russell, ME .

CIRCULATION, 2004, 109 (16) :1942-1947

[37]

Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x

[38]

Zahringer M, 2007, J ENDOVASC THER, V14, P460, DOI 10.1583/1545-1550(2007)14[460:SVBLSF]2.0.CO

[39]

[40] Restenosis after stenting of atherosclerotic renal artery stenosis:: Is there a rationale for the use of drug-eluting stents? [J].

Zeller, Thomas ;

Rastan, Aljoscha ;

Rothenpieler, Uwe ;

Mueller, Christian .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 68 (01) :125-130

← 1 2 3 4 →